STRATA Skin Sciences Appoints William D. Humphries to Its Board of Directors
April 12 2021 - 4:05PM
STRATA Skin Sciences, Inc. (NASDAQ: SSKN), a medical technology
company dedicated to developing, commercializing, and marketing
innovative products for the treatment of dermatologic conditions,
today announced the appointment of William D. Humphries to its
Board of Directors.
Mr. Humphries’ vast experience includes more
than 34 years as a key leader in the pharmaceutical industry,
contributing strategic direction to a range of high growth public
and privately-owned companies.
“We are delighted to welcome Bill to STRATA Skin
Science’s board,” said Uri Geiger, Chairman of STRATA’s Board of
Directors. “His extensive background in the pharmaceutical industry
will provide invaluable leadership as the Company seeks to expand
its role in the dermatologic space.”
From August 2018 until December 2020, Mr.
Humphries served as President and Group Company Chairman, Ortho
Dermatologics of Bausch Health Companies Inc., where he previously
served as Executive Vice President, Company Group Chairman,
Dermatology from January 2017 to August 2018. From 2012 to December
2016, he served as President and Chief Executive Officer of the
North American business of Merz, Inc., an affiliate of Merz Pharma
Group, a specialty healthcare company. From 2004 to 2012, he served
in several leadership positions with Stiefel Laboratories, Inc., a
dermatology pharmaceutical company, including as its Chief
Commercial Officer and then as its President beginning in 2008.
Stiefel was acquired by GlaxoSmithKline in 2009. After the
acquisition, Mr. Humphries served as the President of Dermatology
for Stiefel, a GSK Company from 2009 until 2012. Before Stiefel,
Mr. Humphries served in executive roles in sales and marketing,
business development, and international marketing for Allergan,
Inc., concluding as vice president of its U.S. skincare
business.
“STRATA Skin Sciences has long been at the
forefront of the treatment of dermatologic conditions and I am
excited to join such an impressive team,” said Mr. Humphries. “My
background aligns very well with the Company’s mission and I look
forward to advising on future innovation.”
Mr. Humphries currently serves as Chairman of
the Board at Clearside Biomedical, Chairman of the North Carolina
State University Global Luxury Management Board and is a member of
the Board at Aclaris Therapeutics. He received his MBA from
Pepperdine University and completed his undergraduate studies at
Bucknell University.
About STRATA Skin Sciences,
Inc.
STRATA Skin Sciences is a medical
technology company in dermatology dedicated to developing,
commercializing and marketing innovative products for the treatment
of dermatologic conditions. Its products include the
XTRAC® excimer laser and VTRAC® lamp systems utilized in
the treatment of psoriasis, vitiligo and various other skin
conditions.
The Company’s proprietary XTRAC excimer
laser delivers a highly targeted therapeutic beam of UVB light to
treat psoriasis, vitiligo, eczema, atopic dermatitis and
leukoderma, diseases which impact over 31 million patients
in the United States alone. The technology is covered by
multiple patents.
STRATA’s unique business model leverages
targeted Direct to Consumer (DTC) advertising to generate awareness
and utilizes its in-house call center and insurance advocacy teams
to increase volume for the Company’s partner dermatology
clinics.
Investor Contact
Leigh Salvo |
(415) 937-5404 |
ir@strataskin.com |
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Strata Skin Sciences (NASDAQ:SSKN)
Historical Stock Chart
From Apr 2023 to Apr 2024